Company Filing History:
2 out of 50 
1 out of 36 
1 out of 832,880 Years Active: 2010-2020
Title: The Innovative Contributions of Sandra Schneider in Tumor Diagnostics and Therapy
Introduction
Sandra Schneider, a prominent inventor based in Stutensee, Germany, has made significant strides in the field of biomedicine, particularly in tumor diagnosis and therapy. With a remarkable portfolio of four patents, Schneider's innovative work has opened new avenues in understanding and treating cancer.
Latest Patents
Among her latest patents, Schneider has developed methods focusing on the identification of surface-associated antigens for cancer diagnosis and treatment. One key invention involves the identification of the surface-associated antigen FLJ31461, which pertains to gene products resulting from tumor-associated expression. This groundbreaking work not only addresses the mechanism of tumor progression but also outlines therapies and diagnostic methods relying on these gene products.
Another significant patent features an isolated truncated desmoglein 4 (DSG4) polypeptide splice variant. This invention provides a method for diagnosing cancer by detecting tumor-associated antigens in tissue samples, which is crucial for monitoring patient outcomes and tailoring therapies.
Career Highlights
Sandra Schneider has enjoyed a fruitful career, collaborating with leading pharmaceutical companies such as Ganymed Pharmaceuticals AG and BioNTech AG. Her expertise and innovative mindset have contributed to advancing research and therapeutic approaches in oncology.
Collaborations
Throughout her career, Schneider has worked alongside esteemed colleagues, including Ugur Sahin and Gerd Helftenbein. These collaborations have enhanced her research endeavors and have played a vital role in the success of her patented innovations.
Conclusion
Sandra Schneider's contributions to the field of tumor diagnostics and therapy underscore the importance of innovation in addressing complex health challenges. Her patents not only reflect her inventive spirit but also her commitment to improving cancer treatment and patient care. The ongoing impact of her work continues to inspire future advancements in biomedical research.